425 related articles for article (PubMed ID: 11105929)
1. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
4. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE
Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194
[TBL] [Abstract][Full Text] [Related]
5. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
6. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
7. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
8. Assessment of myocardial viability by positron emission tomography.
Segall G
Nucl Med Commun; 2002 Apr; 23(4):323-30. PubMed ID: 11930185
[TBL] [Abstract][Full Text] [Related]
9. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
10. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose.
Matsunari I; Böning G; Ziegler SI; Nekolla SG; Stollfuss JC; Kosa I; Ficaro EP; Schwaiger M
J Am Coll Cardiol; 1998 Oct; 32(4):927-35. PubMed ID: 9768713
[TBL] [Abstract][Full Text] [Related]
11. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of myocardial viability by FDG-PET].
Momose M; Kondo C
Rinsho Byori; 2007 Jul; 55(7):639-47. PubMed ID: 17718060
[TBL] [Abstract][Full Text] [Related]
13. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
[TBL] [Abstract][Full Text] [Related]
14. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
15. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.
Bax JJ; Cornel JH; Visser FC; Fioretti PM; Huitink JM; van Lingen A; Sloof GW; Visser CA
J Nucl Cardiol; 1997; 4(4):302-8. PubMed ID: 9278877
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
[TBL] [Abstract][Full Text] [Related]
17. Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; Jager PL
Int J Cardiovasc Imaging; 2006 Feb; 22(1):63-80. PubMed ID: 16372139
[TBL] [Abstract][Full Text] [Related]
18. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment.
Zhang X; Liu XJ; Hu S; Schindler TH; Tian Y; He ZX; Gao R; Wu Q; Wei H; Sayre JW; Schelbert HR
J Nucl Med; 2008 Aug; 49(8):1288-98. PubMed ID: 18632821
[TBL] [Abstract][Full Text] [Related]
20. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
Fitzgerald J; Parker JA; Danias PG
J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
